Goodwill and Finite-lived Intangible Assets (Details Narrative) - USD ($) |
3 Months Ended | 6 Months Ended | 12 Months Ended | |||
---|---|---|---|---|---|---|
Jun. 30, 2025 |
Jun. 30, 2024 |
Jun. 30, 2025 |
Jun. 30, 2024 |
Dec. 31, 2024 |
Dec. 31, 2023 |
|
Finite-Lived Intangible Assets [Line Items] | ||||||
Impairment of goodwill | $ 0 | $ 0 | $ 0 | $ 0 | $ 6,058,000 | $ 13,208,276 |
Impairment charge | 50,000.00 | 3,680,000 | ||||
Amortization expense | 630,863 | 1,199,878 | ||||
Impairment charge | 3,090,881 | 5,699,464 | ||||
Marketing-Related Intangible Assets [Member] | ||||||
Finite-Lived Intangible Assets [Line Items] | ||||||
Impairment charge | 50,000.00 | |||||
Impairment charge | 50,000.00 | |||||
Developed Technology Rights [Member] | ||||||
Finite-Lived Intangible Assets [Line Items] | ||||||
Impairment charge | 2,990,000 | $ 2,020,000.00 | ||||
Impairment charge | 2,990,000 | |||||
Customer Relationships [Member] | ||||||
Finite-Lived Intangible Assets [Line Items] | ||||||
Impairment charge | $ 50,000.00 |
X | ||||||||||
- Definition The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Amount of write-down of assets recognized in the income statement. Includes, but is not limited to, losses from tangible assets, intangible assets and goodwill. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
X | ||||||||||
- Definition Amount of impairment loss from asset representing future economic benefit arising from other asset acquired in business combination or from joint venture formation or both, that is not individually identified and separately recognized. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition The amount of impairment loss recognized in the period resulting from the write-down of the carrying amount of a finite-lived intangible asset to fair value. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|